Combined BRAF(V600E) and MEK blockade for BRAF(V600E)-mutant gliomas

BRAF(V600E) is a common finding in glioma (about 10–60% depending on histopathologic subclassification). BRAF(V600E) monotherapy shows modest preclinical efficacy against BRAF(V600E) gliomas and also induces adverse secondary skin malignancies. Here, we examine the molecular mechanism of intrinsic r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurooncol
Main Authors: Zhang, Jie, Yao, Tsun-Wen, Hashizume, Rintaro, Hariono, Sujatmi, Barkovich, Krister J., Fan, Qi-Wen, Prados, Michael, James, C. David, Weiss, William A., Nicolaides, Theodore
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5560871/
https://ncbi.nlm.nih.gov/pubmed/27848137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-016-2333-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados